Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Victory For Device Industry, Supreme Court Favors PMA Pre-emption

This article was originally published in The Gray Sheet

Executive Summary

In a ruling that is expected to shave the volume of lawsuits against device manufacturers, the Supreme Court held that FDA premarket approval should preclude patients from suing companies for personal injury in most cases

You may also be interested in...



COVID-19 Cases Show Device Preemption Prevails, Attorney Says

Recent rulings in COVID-19 cases have produced ‘very good law’ for manufacturers wary of attempts to limit preemption, a lawyer said in a recent webinar on recent developments around device preemption. 

US Rep. DeLauro Reintroduces Device Safety Bill To Remove PMA Product Liability Suit Protections

A US House representative and two co-sponsors have reintroduced the Medical Device Safety Act, which would remove the defense against state product liability suits for premarket-approved devices from the Federal Food, Drug, and Cosmetic Act (FDCA).

Utah Court Case Could Protect Devices From Some Liability

The Utah Supreme Court is reviewing a case that could give device companies some protection from product liability suits. Industry heavyweights including AdvaMed and the Washington Legal Foundation have weighed in by filing briefs supporting defendant Wright Medical.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025810

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel